Back to top anchor

Targeted drug delivery to the stomach

Year:
2021
Duration:
36 months
Approved budget:
$1,191,527.07
Researchers:
Professor Parry Guilford
,
Dr Allan Gamble
,
Dr Jessica Fairhall
Health issue:
Cancer (oncology)
Proposal type:
Project
Lay summary
Cancer drug therapy must find a balance between the inhibition of tumour growth and the unavoidable side effects of treatment. This balance usually involves compromise, leading to sub-optimal tumour inhibition and ‘tolerable’ but still debilitating toxicity to the patient. One means to avoid this compromise is tissue-specific targeting. For most tissues, this is very difficult or impractical. However, the accessibility and unique physiology of the stomach provides a unique opportunity to deliver high-dose cancer chemotherapy to this organ without dose-limiting side effects. We propose to develop a drug delivery system for the better treatment of localised stomach cancer and its precursor lesions.